Funding led by Patient Square Capital follows successful launch of groundbreaking system that delivers highest-resolution view of subcellular, single-molecule, spatial biology MONHEIM AM RHEIN, Germany – Resolve Biosciences, the pioneer in Molecular Cartography™ technology, today announced it has secured a $71 million Series B financing. The latest round of funding was led by Patient Square Capital and included […]
Univercells, a global life science company providing all-round solutions for biologics manufacturing, has raised € 44 million through the first close of its Series D financing round. In addition to the support of existing private and public shareholders, Univercells is very pleased to welcome prominent new investors from Belgium and the United States. Brussels (Belgium) […]
The company uses computational design to control the function of RNA for molecular detection and therapeutics. SEATTLE — RNA design company Wayfinder Biosciences announced today that it raised a $3.5 million series seed round led by Notation Capital and Divergent Capital to continue its groundbreaking work in the use of RNA as a detection and therapeutic platform. RNA […]
SAN DIEGO, Calif. – Pleno Inc., a multi-omic instrument platform company revolutionizing biological target detection for clinical testing and biomedical research, announced the close of $40 million in Series A financing led by Deerfield Management Company with participation by Foresite Capital. Launched in 1994, Deerfield Management Company is an investment firm dedicated to advancing healthcare through information, investment, and […]
Munich – Biotech startup IRUBIS, has raised EUR 2.8m in a seed financing round. The round was led by High -Tech Gründerfonds (HTGF), Verve Ventures and Ventura BioMed Investors with the participation of EIC Fund, the Initiative for Industrial Innovators and a number of business angels from the biotech industry or Munich startup scene. IRUBIS […]
At today’s Capital Markets Day, Merck KGaA, Darmstadt, Germany, announced its intention to further expand its leadership in science and technology despite the currently challenging operating environment. DARMSTADT, GERMANY “Big 3” expected to generate around 80% of sales growth and > 50% of total sales in 2025 Strategic and targeted investments for annual organic increase in […]
RNA synthesis platform to target synthesis lengths greater than 100-nt, large-scale GMP manufacturing, and novel therapeutic modifications in collaboration with industry partners Advanced-stage technology with over six years of development at the Wyss Institute at Harvard University, co-founded by Dr. George Church of Harvard Medical School, and the first spin-out from the Northpond Labs Alliance […]
Funding will support expanded offerings for drug development, regenerative medicine as fiber-optic instrument-maker broadens presence in life science market New investment will also bolster leadership team and support U.S. expansion AMSTERDAM – Optics11 Life, the fiber optics life science instrumentation company, announced today €5 million in new venture capital from FORWARD.one and returning investor Value […]
SAN DIEGO — iXCells Biotechnologies (“iXCells” or the “Company”), a high growth provider of cell-based products and discovery services to the academic, biotech and pharmaceutical communities worldwide, with special focus on primary and induced pluripotent stem cell (“iPSC”) derived cellular models, today announced receiving a growth investment from Connecticut-based Great Point Partners (“GPP”), a private […]
NEW YORK — Kaleidoscope, pioneering an operating system to accelerate research team performance, today announced the completion of a $6M seed financing round, co-led by Hummingbird Ventures and Dimension, with participation from Caffeinated Capital, SV Angel, Hawktail, and individual investors. The funding will be used to invest in product development and team expansion, with a […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
